1
--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 26, 2001
CardioGenesis Corporation
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
California 000-28288 77-0223740
---------------------------- ----------- -------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
26632 Towne Center Drive, Suite 320,
Foothill Ranch, California 92610
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (714) 649-5000
Eclipse Surgical Technologies, Inc.
1049 Kiel Court, Sunnyvale, California 94089
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
--------------------------------------------------------------------------------
1
2
ITEM 5. OTHER EVENTS
On July 26, 2001, CardioGenesis Corporation, the Registrant, issued a
press release announcing its second quarter 2001 financial results. A copy of
the press release is filed as Exhibit 99.1 and incorporated herein by reference.
ITEM 7. FINANCIAL INFORMATION, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(a) Not applicable
(b) Not applicable
(c) Exhibits:
Pursuant to General Instruction F of Form 8-K, the following
documents are incorporated by reference herein and attached as exhibits
hereto:
EXHIBIT DESCRIPTION
------- -----------
99.1 Press release of the Registrant, dated July 26, 2001,
announcing operating results for the second quarter
ended June 30, 2001.
2
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this current report to be signed on its behalf by the
undersigned hereunto duly authorized.
CARDIOGENESIS CORPORATION
Date: July 26, 2001 By: /s/ J. Stephen Wilkins
-------------------------------------
J. Stephen Wilkins
Chief Financial Officer
3
4
EXHIBIT INDEX
EXHIBIT DESCRIPTION
------- -----------
99.1 Press release of the Registrant, dated July 26, 2001,
announcing operating results for the second quarter
ended June 30, 2001.
4